Author:
Eagle Tessa,Stuart Fiona,Chua Alicia S.,LaRussa Allison,Leclaire Kaitlynne,Cook Sandra L.,Chitnis Tanuja,Weiner Howard L.,Glanz Bonnie I.,Healy Brian C.
Funder
Merck Serono S.A.
Octave Biosciences and Verily Life Sciences
Bayer
Novartis
Roche-Genentech
Genzyme
Subject
Clinical Neurology,Neurology,General Medicine
Reference26 articles.
1. Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study;Agashivala;BMC Neurol.,2013
2. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease;Atkinson;Health Qual. Life Outcomes,2004
3. A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence;Barbosa;Patient Prefer. Adherence,2012
4. Adjusting for multiple testing—when and how?;Bender;J. Clin. Epidemiol.,2001
5. Relapse rates in patients with multiple sclerosis switching from interferon to fingolimod or glatiramer acetate: a US claims database study;Bergvall;PloS One,2014
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献